PERSEPHONE: are we ready to de-escalate adjuvant trastuzumab for HER2-positive breast cancer?

Auteurs : Pondé N, Gelber Rd, Piccart-Gebhart M
Jaar : 2019
Journal : NPJ Breast Cancer
Volume : 5
Pagina's : 1